These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18991035)

  • 1. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.
    Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S
    Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis.
    Avunduk AM; Avunduk MC; Erdöl H; Kapicioglu Z; Akyol N
    Ophthalmologica; 2001; 215(4):290-3. PubMed ID: 11399937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial.
    Keklikci U; Dursun B; Cingu AK
    Adv Clin Exp Med; 2014; 23(3):455-61. PubMed ID: 24979519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
    Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
    Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
    Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
    Ozcan AA; Ersoz TR; Dulger E
    Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.
    Yücel OE; Ulus ND
    Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients].
    Spadavecchia L; Fanelli P; Tesse R; Rizzo G; Procoli U; Bellizzi M; Armenio L
    Minerva Pediatr; 2010 Jun; 62(3):239-44. PubMed ID: 20467374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.
    Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L
    Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
    De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
    Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vernal keratoconjunctivitis in Thailand.
    Kosrirukvongs P; Vichyanond P; Wongsawad W
    Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topical 0.05% cyclosporine treatment in children with severe vernal keratoconjunctivitis.
    Çoban-Karataş M; Özkale Y; Altan-Yaycıoğlu R; Sızmaz S; Pelit A; Metindoğan S; Cantürk-Uğurbaş S; Aydın-Akova Y
    Turk J Pediatr; 2014; 56(4):410-7. PubMed ID: 25818961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q; Tang J; Han Y; Wang D; Ye H
    Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children.
    Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
    Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
    Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
    Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
    Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.
    Oray M; Toker E
    Cornea; 2013 Aug; 32(8):1149-54. PubMed ID: 23676782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.